The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Nephrotoxicity From Chemotherapeutic Agents: Clinical Manifestations, Pathobiology, and Prevention/Therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Pabla, N., & Dong, Z. (2008) · Kidney International · doi:10.1038/sj.ki.5002786 · Cited by 1,918
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
Ramesh, G., & Reeves, W. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15606 · Cited by 866
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Ulrich, C. M., Bigler, J., & Potter, J. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1801 · Cited by 548
Sugimoto, H., Hamano, Y., Charytan, D., Cosgrove, D., Kieran, M., Sudhakar, A., & Kalluri, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300012200 · Cited by 538
Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
MARKOWITZ, G. S., APPEL, G. B., FINE, P. L., FENVES, A. Z., LOON, N. R., JAGANNATH, S., KUHN, J. A., DRATCH, A. D., & D'AGATI, V. D. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261164 · Cited by 466
Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2
Ciarimboli, G., Ludwig, T., Lang, D., Pavenstädt, H., Koepsell, H., Piechota, H.-J., Haier, J., Jaehde, U., Zisowsky, J., & Schlatter, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61234-5 · Cited by 448
Renal Vulnerability to Drug Toxicity
Perazella, M. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02050309 · Cited by 403
Self-citationAdverse Effects of Bisphosphonates: A Comparative Review
Adami, S., & Zamberlan, N. (1996) · Drug Safety · doi:10.2165/00002018-199614030-00003 · Cited by 377
Perazella, M. A., & Markowitz, G. S. (2008) · Kidney International · doi:10.1038/ki.2008.356 · Cited by 363
Self-citationAnticancer Drug???Induced Kidney Disorders: Incidence, Prevention and Management
Kintzel, P. E. (2001) · Drug Safety · doi:10.2165/00002018-200124010-00003 · Cited by 355
Crystal-induced acute renal failure
Perazella, M. A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00041-8 · Cited by 322
Self-citationMetabolism of Cisplatin to a Nephrotoxin in Proximal Tubule Cells
Townsend, D. M., Deng, M., Zhang, L., Lapus, M. G., & Hanigan, M. H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000042803.28024.92 · Cited by 317
TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure
Ramesh, G., & Reeves, W. B. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2003 · Cited by 282
Faubel, S., Ljubanovic, D., Reznikov, L., Somerset, H., Dinarello, C. A., & Edelstein, C. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66010.x · Cited by 196
Chemotherapy-associated renal dysfunction
Sahni, V., Choudhury, D., & Ahmed, Z. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.97 · Cited by 183
Enomoto, A., & Endou, H. (2005) · Clinical and Experimental Nephrology · doi:10.1007/s10157-005-0368-5 · Cited by 181
Renal Failure Associated with Cancer and Its Treatment: An Update
Humphreys, B. D., Soiffer, R. J., & Magee, C. C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100843 · Cited by 179
Relationship of Intracellular Calcium and Oxygen Radicals to Cisplatin-Related Renal Cell Injury
Kawai, Y., Nakao, T., Kunimura, N., Kohda, Y., & Gemba, M. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050661 · Cited by 176
Renal Effects of Anti-angiogenesis Therapy: Update for the Internist
Gurevich, F., & Perazella, M. A. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.11.025 · Cited by 170
Self-citationChirino, Y. I., Hernández‐Pando, R., & Pedraza‐Chaverrí, J. (2004) · BMC Pharmacology · doi:10.1186/1471-2210-4-20 · Cited by 149
Acute renal failure in cancer patients
Lameire, N. H., Flombaum, C. D., Moreau, D., & Ronco, C. (2005) · Annals of Medicine · doi:10.1080/07853890510007205 · Cited by 130
How to prevent, recognize, and treat drug-induced nephrotoxicity.
Guo, X., & Nzerue, C. M. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.4.289 · Cited by 112
YILMAZ, H., İraz, M., SOGUT, S., Özyurt, H., Yıldırım, Z., Akyol, Ö., & Gergerlioğlu, H. S. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.03.003 · Cited by 97
Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity
Aleksa, K., Matsell, D. G., Krausz, K., Gelboin, H. V., Ito, S., & Koren, G. (2005) · Pediatric Nephrology · doi:10.1007/s00467-004-1807-3 · Cited by 82
Singh, N. P., Ganguli, A., & Prakash, A. (2003) · PubMed · Cited by 78
Ifosfamide Metabolite Chloroacetaldehyde Causes Fanconi Syndrome in the Perfused Rat Kidney
Zamlauski-Tucker, M. J., Morris, M. E., & Springate, J. E. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1241 · Cited by 73
Jerkić, M., Vojvodić, S., & López-Novoa, J. M. (2001) · International Urology and Nephrology · doi:10.1023/a:1014484101427 · Cited by 65
Renal Toxicities of Chemotherapy
de Jonge, M. J. A., & Verweij, J. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.11.011 · Cited by 63
Evenepoel, P. (2004) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2003.09.007 · Cited by 62
Fox, N. L., Humphreys, R. C., Luster, T. A., Klein, J. L., & Gallant, G. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903319656 · Cited by 62
de Miguel, D., García‐Suárez, J., Martín, Y. P., et al. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn503 · Cited by 47
Sauter, M., Jülg, B. D., Porubský, Š., Cohen, C., Fischereder, M., Sitter, T., Schlöndorff, D., & Gröne, H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.02.189 · Cited by 42
Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosis
Lockridge, L., Papac, R. J., & Perazella, M. A. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33933 · Cited by 41
Self-citationRace and Ethnicity in the Era of Emerging Pharmacogenomics
Harty, L. C., Johnson, K. J., & Power, A. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005286028 · Cited by 27
Altered expression of methylenetetrahydrofolate reductase modifies response to methotrexate in mice
Çeltikçi, B., Leclerc, D., Lawrance, A. K., Deng, L.-Y., Friedman, H. C., Krupenko, N. I., Krupenko, S. A., Melnyk, S., James, S. J., Peterson, A. C., et al. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32830058aa · Cited by 19
Cited by
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Preventing and Managing Toxicities of High-Dose Methotrexate
Howard, S. C., McCormick, J., Pui, C.-H., Buddington, R. K., & Harvey, R. D. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0164 · Cited by 929
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
van den Boogaard, W. M. C., Komninos, D. S. J., & Vermeij, W. P. (2022) · Cancers · doi:10.3390/cancers14030627 · Cited by 458
Drug-Induced Acute Kidney Injury
Perazella, M. A., & Rosner, M. H. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11290821 · Cited by 357
Self-citationProtective Role for Antioxidants in Acute Kidney Disease
Dennis, J., & Witting, P. (2017) · Nutrients · doi:10.3390/nu9070718 · Cited by 291
Metadata
- Authors
- Perazella, M. A., & Moeckel, G. W.
- Venue
- Seminars in Nephrology
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 30
- Issue
- 6
- Pages
- 570-581
- ISSN
- 0270-9295 (ISSN-L)
- OpenAlex
- W2028367795
- Cited by
- 287
- References
- 37
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.